Exogenous glucagon-like peptide-1 reduces body weight and cholecystokinin-8 enhances this reduction in diet-induced obese male rats

- We hypothesized that infusing GLP-1 near its site of action reduces BW.
- Combining CCK-8 to this infusion enhances the reduction.
- GLP-1 and GLP-1 + CCK-8 decrease BW.
- GLP-1 + CCK-8 reduced it more than GLP-1 alone.
- Given near their sites of action GLP-1 reduces BW and CCK-8 enhances it.

The sites of action regulating meal size (MS) and intermeal interval (IMI) length by glucagon like peptide-1 (7-36) (GLP-1 (7-36)) and cholecystokinin-8 (CCK-8) reside in the areas supplied by the two major branches of the abdominal aorta, celiac and cranial mesenteric arteries. We hypothesized that infusing GLP-1 near those sites reduces body weight (BW) and adding CCK-8 to this infusion enhances the reduction. Here, we measured BW in diet-induced obese (DIO) male rats maintained and tested on normal rat chow and infused with saline, GLP-1 (0.5 nmol/kg) and GLP-1 + CCK-8 (0.5 nmol/kg each) in the aorta once daily for 21 days. We found that GLP-1 and GLP-1 + CCK-8 decrease BW relative to saline vehicle and GLP-1 + CCK-8 reduced it more than GLP-1 alone. Reduction of BW by GLP-1 alone was accompanied by decreased 24-h food intake, first MS, duration of first meal and number of meals, and an increase in latency to first meal. Reduction of BW by the combination of the peptides was accompanied by decrease 24-h food intake, first MS, duration of first meal and number of meals, and increase in the IMI length, satiety ratio and latency to first meal. In conclusion, GLP-1 reduces BW and CCK-8 enhances this reduction if the peptides are given near their sites of action.